At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits per month in the period from December 2023 to November 2024. The multitude of suits include many that stem from generic drugmakers’ plans to sell lower-priced versions of recognized pharmaceutical products.

Click Here To Read The Full Article